首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7 receptors
【2h】

The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7 receptors

机译:非典型抗精神病药氯氮平和奥氮平可促进下调并在人类5-HT7受体上显示功能选择性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background and PurposeClassically, ligands of GPCRs have been classified primarily upon their affinity and efficacy to activate a signal transduction pathway. Recent reports indicate that the efficacy of a particular ligand can vary depending on the receptor-mediated response measured (e.g. activating G proteins, other downstream responses, internalization). Previously, we reported that inverse agonists induce both homo- and heterologous desensitization, similar to agonist stimulation, at the Gs-coupled 5-HT7 receptor. The primary objective of this study was to determine whether different inverse agonists at the 5-HT7 receptor also induce internalization and/or degradation of 5-HT7 receptors.
机译:背景和目的通常,GPCR的配体主要根据其亲和力和激活信号转导途径的功效进行分类。最近的报道表明,特定配体的功效可以根据所测量的受体介导的反应(例如,活化G蛋白,其他下游反应,内在化)而变化。以前,我们报道了反向激动剂在Gs偶联的5-HT7受体上诱导同源和异源脱敏,类似于激动剂刺激。这项研究的主要目的是确定在5-HT7受体上不同的反向激动剂是否也诱导5-HT7受体的内在化和/或降解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号